Sepsis Treatment Market in Germany - Industry Outlook and Forecast 2020-2026

Publisher Name :
Date: 30-Apr-2020
No. of pages: 101

Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.

This report contains market size and forecasts of Sepsis Treatment in Germany, including the following market information:

Germany Sepsis Treatment Market Revenue, 2015-2020, 2021-2026, ($ millions)

Top Five Competitors in Germany Sepsis Treatment Market 2019 (%)

The global Sepsis Treatment market was valued at 3007.8 million in 2019 and is projected to reach US$ 3858 million by 2026, at a CAGR of 6.4% during the forecast period. While the Sepsis Treatment market size in Germany was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.

COVID-19 pandemic has big impact on Sepsis Treatment businesses, with lots of challenges and uncertainty faced by many players of Sepsis Treatment in Germany.

This report also analyses and evaluates the COVID-19 impact on Sepsis Treatment market size in 2020 and the next few years in Germany

Total Market by Segment:

Germany Sepsis Treatment Market, By Type, 2015-2020, 2021-2026 ($ millions)

Germany Sepsis Treatment Market Segment Percentages, By Type, 2019 (%)

- Cephalosporin

- Pencillin

- Macrolides

- Others

Germany Sepsis Treatment Market, By Application, 2015-2020, 2021-2026 ($ millions)

Germany Sepsis Treatment Market Segment Percentages, By Application, 2019 (%)

- Sepsis

- Severe Sepsis

- Septic Shock

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Sepsis Treatment Market Competitors Revenues in Germany, by Players 2015-2020 (Estimated), ($ millions)

Total Sepsis Treatment Market Competitors Revenues Share in Germany, by Players 2019 (%)

Further, the report presents profiles of competitors in the market, including the following:

- Pfizer

- NCPC

- Bayer

- Shanghai Pharmaceuticals

- Johnson & Johnson

- Novartis

- GlaxoSmithKline

- TEVA

- Mylan

- Allergan

- Merck & Co

- Asahi Kasei Corporation

- AtoxBio

- INOTREM

- Adrenomed

Sepsis Treatment Market in Germany - Industry Outlook and Forecast 2020-2026

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Sepsis Treatment Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 COVID-19 Impact: Germany Sepsis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats

2 Germany Sepsis Treatment Overall Market Size
2.1 Germany Sepsis Treatment Market Size: 2020 VS 2026
2.2 Germany Sepsis Treatment Revenue, Prospects & Forecasts: 2015-2026

3 Company Landscape
3.1 Top Sepsis Treatment Players in Germany (including Foreign and Local Companies)
3.2 Top Germany Sepsis Treatment Companies Ranked by Revenue
3.3 Germany Sepsis Treatment Revenue by Companies (including Foreign and Local Companies)
3.4 Top 3 and Top 5 Sepsis Treatment Companies in Germany, by Revenue in 2019
3.5 Germany Manufacturers Sepsis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Sepsis Treatment Players in Germany
3.6.1 List of Germany Tier 1 Sepsis Treatment Companies
3.6.2 List of Germany Tier 2 and Tier 3 Sepsis Treatment Companies

4 Sights by Product
4.1 Overview
4.1.1 By Type - Germany Sepsis Treatment Market Size Markets, 2020 & 2026
4.1.2 Cephalosporin
4.1.3 Pencillin
4.1.4 Macrolides
4.1.5 Others
4.2 By Type - Germany Sepsis Treatment Revenue & Forecasts
4.2.1 By Type - Germany Sepsis Treatment Revenue, 2015-2020
4.2.2 By Type - Germany Sepsis Treatment Revenue, 2021-2026
4.2.3 By Type - Germany Sepsis Treatment Revenue Market Share, 2015-2026
5 Sights by Application
5.1 Overview
5.1.1 By Application - Germany Sepsis Treatment Market Size, 2020 & 2026
5.1.2 Sepsis
5.1.3 Severe Sepsis
5.1.4 Septic Shock
5.2 By Application - Germany Sepsis Treatment Revenue & Forecasts
5.2.1 By Application - Germany Sepsis Treatment Revenue, 2015-2020
5.2.2 By Application - Germany Sepsis Treatment Revenue, 2021-2026
5.2.3 By Application - Germany Sepsis Treatment Revenue Market Share, 2015-2026
6 Players Profiles
6.1 Pfizer
6.1.1 Pfizer Corporate Summary
6.1.2 Pfizer Business Overview
6.1.3 Pfizer Sepsis Treatment Major Product Offerings
6.1.4 Pfizer Revenue in Germany (2015-2020)
6.1.5 Pfizer Key News
6.2 NCPC
6.2.1 NCPC Corporate Summary
6.2.2 NCPC Business Overview
6.2.3 NCPC Sepsis Treatment Major Product Offerings
6.2.4 NCPC Revenue in Germany (2015-2020)
6.2.5 NCPC Key News
6.3 Bayer
6.3.1 Bayer Corporate Summary
6.3.2 Bayer Business Overview
6.3.3 Bayer Sepsis Treatment Major Product Offerings
6.3.4 Bayer Revenue in Germany (2015-2020)
6.3.5 Bayer Key News
6.4 Shanghai Pharmaceuticals
6.4.1 Shanghai Pharmaceuticals Corporate Summary
6.4.2 Shanghai Pharmaceuticals Business Overview
6.4.3 Shanghai Pharmaceuticals Sepsis Treatment Major Product Offerings
6.4.4 Shanghai Pharmaceuticals Revenue in Germany (2015-2020)
6.4.5 Shanghai Pharmaceuticals Key News
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporate Summary
6.5.2 Johnson & Johnson Business Overview
6.5.3 Johnson & Johnson Sepsis Treatment Major Product Offerings
6.5.4 Johnson & Johnson Revenue in Germany (2015-2020)
6.5.5 Johnson & Johnson Key News
6.6 Novartis
6.6.1 Novartis Corporate Summary
6.6.2 Novartis Business Overview
6.6.3 Novartis Sepsis Treatment Major Product Offerings
6.6.4 Novartis Revenue in Germany (2015-2020)
6.6.5 Novartis Key News
6.7 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporate Summary
6.6.2 GlaxoSmithKline Business Overview
6.6.3 GlaxoSmithKline Sepsis Treatment Major Product Offerings
6.4.4 GlaxoSmithKline Revenue in Germany (2015-2020)
6.7.5 GlaxoSmithKline Key News
6.8 TEVA
6.8.1 TEVA Corporate Summary
6.8.2 TEVA Business Overview
6.8.3 TEVA Sepsis Treatment Major Product Offerings
6.8.4 TEVA Revenue in Germany (2015-2020)
6.8.5 TEVA Key News
6.9 Mylan
6.9.1 Mylan Corporate Summary
6.9.2 Mylan Business Overview
6.9.3 Mylan Sepsis Treatment Major Product Offerings
6.9.4 Mylan Revenue in Germany (2015-2020)
6.9.5 Mylan Key News
6.10 Allergan
6.10.1 Allergan Corporate Summary
6.10.2 Allergan Business Overview
6.10.3 Allergan Sepsis Treatment Major Product Offerings
6.10.4 Allergan Revenue in Germany (2015-2020)
6.10.5 Allergan Key News
6.11 Merck & Co
6.11.1 Merck & Co Corporate Summary
6.11.2 Merck & Co Sepsis Treatment Business Overview
6.11.3 Merck & Co Sepsis Treatment Major Product Offerings
6.11.4 Merck & Co Revenue in Germany (2015-2020)
6.11.5 Merck & Co Key News
6.12 Asahi Kasei Corporation
6.12.1 Asahi Kasei Corporation Corporate Summary
6.12.2 Asahi Kasei Corporation Sepsis Treatment Business Overview
6.12.3 Asahi Kasei Corporation Sepsis Treatment Major Product Offerings
6.12.4 Asahi Kasei Corporation Revenue in Germany (2015-2020)
6.12.5 Asahi Kasei Corporation Key News
6.13 AtoxBio
6.13.1 AtoxBio Corporate Summary
6.13.2 AtoxBio Sepsis Treatment Business Overview
6.13.3 AtoxBio Sepsis Treatment Major Product Offerings
6.13.4 AtoxBio Revenue in Germany (2015-2020)
6.13.5 AtoxBio Key News
6.14 INOTREM
6.14.1 INOTREM Corporate Summary
6.14.2 INOTREM Sepsis Treatment Business Overview
6.14.3 INOTREM Sepsis Treatment Major Product Offerings
6.14.4 INOTREM Revenue in Germany (2015-2020)
6.14.5 INOTREM Key News
6.15 Adrenomed
6.15.1 Adrenomed Corporate Summary
6.15.2 Adrenomed Sepsis Treatment Business Overview
6.15.3 Adrenomed Sepsis Treatment Major Product Offerings
6.15.4 Adrenomed Revenue in Germany (2015-2020)
6.15.5 Adrenomed Key News
6.16 Endacea
6.16.1 Endacea Corporate Summary
6.16.2 Endacea Sepsis Treatment Business Overview
6.16.3 Endacea Sepsis Treatment Major Product Offerings
6.16.4 Endacea Revenue in Germany (2015-2020)
6.16.5 Endacea Key News

7 Key Market Trends & Influences 2021-2026
7.1 PESTLE Analysis for Germany Sepsis Treatment Market
7.2 Market Opportunities & Trends
7.3 Market Drivers
7.4 Market Restraints

8 Conclusion

9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables

Table 1. Key Players of Sepsis Treatment in Germany
Table 2. Top Players in Germany, Ranking by Revenue (2019)
Table 3. Germany Sepsis Treatment Revenue by Companies, (US$, Mn), 2015-2020
Table 4. Germany Sepsis Treatment Revenue Share by Companies, 2015-2020
Table 5. Germany Sepsis Treatment Sales by Companies, (K Units), 2015-2020
Table 6. Germany Sepsis Treatment Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Sepsis Treatment Price (2015-2020) (US$/Unit)
Table 8. Germany Manufacturers Sepsis Treatment Product Type
Table 9. List of Germany Tier 1 Sepsis Treatment Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of Germany Tier 2 and Tier 3 Sepsis Treatment Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Sepsis Treatment Revenue in Germany (US$, Mn), 2015-2020
Table 12. By Type - Sepsis Treatment Revenue in Germany (US$, Mn), 2021-2026
Table 13. By Type - Sepsis Treatment Sales in Germany (K Units), 2015-2020
Table 14. By Type - Sepsis Treatment Sales in Germany (K Units), 2021-2026
Table 15. By Application - Sepsis Treatment Revenue in Germany, (US$, Mn), 2015-2020
Table 16. By Application - Sepsis Treatment Revenue in Germany, (US$, Mn), 2021-2026
Table 17. By Application - Sepsis Treatment Sales in Germany, (K Units), 2015-2020
Table 18. By Application - Sepsis Treatment Sales in Germany, (K Units), 2021-2026
Table 19. Pfizer Corporate Summary
Table 20. Pfizer Sepsis Treatment Product Offerings
Table 21. Pfizer Sepsis Treatment Revenue (US$, Mn), (2015-2020)
Table 22. NCPC Corporate Summary
Table 23. NCPC Sepsis Treatment Product Offerings
Table 24. NCPC Sepsis Treatment Revenue (US$, Mn), (2015-2020)
Table 25. Bayer Corporate Summary
Table 26. Bayer Sepsis Treatment Product Offerings
Table 27. Bayer Sepsis Treatment Revenue (US$, Mn), (2015-2020)
Table 28. Shanghai Pharmaceuticals Corporate Summary
Table 29. Shanghai Pharmaceuticals Sepsis Treatment Product Offerings
Table 30. Shanghai Pharmaceuticals Sepsis Treatment Revenue (US$, Mn), (2015-2020)
Table 31. Johnson & Johnson Corporate Summary
Table 32. Johnson & Johnson Sepsis Treatment Product Offerings
Table 33. Johnson & Johnson Sepsis Treatment Revenue (US$, Mn), (2015-2020)
Table 34. Novartis Corporate Summary
Table 35. Novartis Sepsis Treatment Product Offerings
Table 36. Novartis Sepsis Treatment Revenue (US$, Mn), (2015-2020)
Table 37. GlaxoSmithKline Corporate Summary
Table 38. GlaxoSmithKline Sepsis Treatment Product Offerings
Table 39. GlaxoSmithKline Sepsis Treatment Revenue (US$, Mn), (2015-2020)
Table 40. TEVA Corporate Summary
Table 41. TEVA Sepsis Treatment Product Offerings
Table 42. TEVA Sepsis Treatment Revenue (US$, Mn), (2015-2020)
Table 43. Mylan Corporate Summary
Table 44. Mylan Sepsis Treatment Product Offerings
Table 45. Mylan Sepsis Treatment Revenue (US$, Mn), (2015-2020)
Table 46. Allergan Corporate Summary
Table 47. Allergan Sepsis Treatment Product Offerings
Table 48. Allergan Sepsis Treatment Revenue (US$, Mn), (2015-2020)
Table 49. Merck & Co Corporate Summary
Table 50. Merck & Co Sepsis Treatment Product Offerings
Table 51. Merck & Co Sepsis Treatment Revenue (US$, Mn), (2015-2020)
Table 52. Asahi Kasei Corporation Corporate Summary
Table 53. Asahi Kasei Corporation Sepsis Treatment Product Offerings
Table 54. Asahi Kasei Corporation Sepsis Treatment Revenue (US$, Mn), (2015-2020)
Table 55. AtoxBio Corporate Summary
Table 56. AtoxBio Sepsis Treatment Product Offerings
Table 57. AtoxBio Sepsis Treatment Revenue (US$, Mn), (2015-2020)
Table 58. INOTREM Corporate Summary
Table 59. INOTREM Sepsis Treatment Product Offerings
Table 60. INOTREM Sepsis Treatment Revenue (US$, Mn), (2015-2020)
Table 61. Adrenomed Corporate Summary
Table 62. Adrenomed Sepsis Treatment Product Offerings
Table 63. Adrenomed Sepsis Treatment Revenue (US$, Mn), (2015-2020)
Table 64. Endacea Corporate Summary
Table 65. Endacea Sepsis Treatment Product Offerings
Table 66. Endacea Sepsis Treatment Revenue (US$, Mn), (2015-2020)

List of Figures

Figure 1. Sepsis Treatment Segment by Type
Figure 2. Sepsis Treatment Segment by Application
Figure 3. Germany Sepsis Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Sepsis Treatment Market Size in Germany, (US$, Mn): 2020 VS 2026
Figure 6. Germany Sepsis Treatment Revenue, 2015-2026 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Sepsis Treatment Revenue in 2019
Figure 8. By Type - Germany Sepsis Treatment Incremental Growth, (US$, Mn), 2015-2026
Figure 9. By Type - Germany Sepsis Treatment Market Share, 2015-2026
Figure 10. By Application - Sepsis Treatment Revenue in Germany (US$, Mn), 2020 & 2026
Figure 11. By Application - Germany Sepsis Treatment Market Share, 2015-2026
Figure 12. PEST Analysis for Germany Sepsis Treatment Market in 2020
Figure 13. Sepsis Treatment Market Opportunities & Trends in Germany
Figure 14. Sepsis Treatment Market Drivers in Germany
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs